A detailed history of Inspire Investing, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 25,088 shares of NEO stock, worth $363,776. This represents 0.04% of its overall portfolio holdings.

Number of Shares
25,088
Previous 22,657 10.73%
Holding current value
$363,776
Previous $356,000 2.53%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$13.01 - $15.77 $31,627 - $38,336
2,431 Added 10.73%
25,088 $347,000
Q1 2024

May 07, 2024

SELL
$14.06 - $16.79 $21,174 - $25,285
-1,506 Reduced 6.23%
22,657 $356,000
Q4 2023

Feb 12, 2024

SELL
$11.67 - $20.73 $17,458 - $31,012
-1,496 Reduced 5.83%
24,163 $390,000
Q3 2023

Oct 26, 2023

BUY
$12.15 - $17.85 $311,756 - $458,013
25,659 New
25,659 $315,000
Q1 2021

Apr 30, 2021

SELL
$41.56 - $59.88 $363,566 - $523,830
-8,748 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$36.08 - $56.47 $315,627 - $493,999
8,748 New
8,748 $470,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.82B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.